Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Angiogenesis >  VDA chemical products >  Vadimezan

Vadimezan

Basic information Safety Supplier Related

Vadimezan Basic information

Product Name:
Vadimezan
Synonyms:
  • CS-1975
  • DMXAA (ASA404,Vadimezan)
  • 5,6-dimethylxanthenoneacetic acid
  • DMXAA
  • vadimezan
  • (5,6-DIMETHYL-9-OXO-XANTHEN)-4-ACETIC ACID
  • 5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic acid
  • 5,6-Dimethylxanthenone-4-acetic acid
CAS:
117570-53-3
MF:
C17H14O4
MW:
282.29
EINECS:
700-141-4
Product Categories:
  • Inhibitors
Mol File:
117570-53-3.mol
More
Less

Vadimezan Chemical Properties

Melting point:
259-261 °C
Boiling point:
520.9±50.0 °C(Predicted)
Density 
1.321±0.06 g/cm3(Predicted)
vapor pressure 
0Pa at 20℃
storage temp. 
2-8°C
solubility 
DMSO: 17 mg/mL, soluble
form 
solid
pka
4.21±0.10(Predicted)
color 
light brown
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO or DMF may be stored at -20°C for up to 3 months.
More
Less

Safety Information

Hazard Codes 
Xn,N
Risk Statements 
22-50/53
Safety Statements 
60-61
RIDADR 
UN 3077 9/PG 3
WGK Germany 
3
RTECS 
ZD5536200
HS Code 
2932.99.7000
More
Less

Vadimezan Usage And Synthesis

Description

DMXAA (117570-53-3) is a STING (Stimulator of Interferon Genes) agonist selective for mouse STING.1,2 Intratumoral administration of DMXAA resulted in tumor regression and complete rejection in mouse xenografts.3 Tumor regression induced by DMXAA results from a cascade of cellular events which include disruption of tumor vasculature followed by the release of chemokines which trigger the recruitment of immune cells.4 DMXAA induced expression of IFN-β resulting in a striking expansion of leukemia-specific T cells extending survival in two acute myeloid leukemia models.5

Uses

Vadimezan is a drug that displayed vascular-disrupting activity and induced haemorrhagic necrosis and tumour regression in pre-clinical animal models. It is a substrate for the immune adaptor protein STING in mice.

Definition

ChEBI: A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is replaced by a 5,6-dimethyl-9-oxoxanthen-4-yl group.

General Description

5,6-dimethylxanthenone-4-acetic acid (DMXAA) is a flavone acetic acid derivative. It acts as a vascular disrupting agent (VDA), which damages tumor vasculature and stimulates an anti-tumor immune response. It stimulates hemorrhagic necrosis.

Biochem/physiol Actions

DMXAA is an apoptosis inducer; anti-vascular.

storage

Store at +4°C

References

1) Prantner et al. (2012), 5,6-Dimethylzanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential; J. Biol. Chem., 287 39776 2) Conlon et al. (2013), Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid; J. Immunol., 190 5216 3) Corrales et al. (2015), Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and immunity; Cell Rep., 11 1018 4) Weiss et al. (2017), The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression; Oncoimmunology, 6 e1346765 5) Curran et al. (2016), STING Pathway Activation Stimulates Potent Immunity Against Acute Myeloid Leukemia; Cell Rep., 15 2357

VadimezanSupplier

Wuhan Jingkangen Biomedical Technology Co., Ltd Gold
Tel
00-13720134139 +86 -0-15871494362 13720134139
Email
orders@jknbiochem.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Chembest Research Laboratories Limited
Tel
021-20908456
Email
sales@BioChemBest.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com